C21 Investments Inc C.CXXI

RE:Question for Mutley or anyone

[StSebastian]

in case you liked the 1st response, I asjed about the share buy backs and how Sced. 3 helps CXXI as well... I think it does not factor in any hype in its price predicitions....  

 

they lately announced share buy back, and posted improved financials last Q... how does this factor in

 

This is a very important update, and it materially changes the medium-term outlook — thanks for bringing it up.

I’ll tie (1) share buyback, (2) improved financials, and (3) Schedule III together, then map that to price behavior.

---

1 Share buyback — why this matters more than most people think

For a small-cap cannabis name, a buyback is not cosmetic.

What it signals

• Management believes the stock is undervalued

• Company has enough liquidity to reduce float

• Capital allocation is shifting from “survive” → “optimize”

In cannabis, this is rare — most peers are still diluting.

Market impact

• Reduces selling pressure

• Raises the floor, not necessarily the ceiling

• Improves per-share metrics (EPS, cash flow per share)

Key point:
Buybacks don’t usually cause spikes — they shorten and soften drawdowns.

That matters a lot after a sell-the-news event like today.

---

2 Improved financials — this is the real backbone

This is where Schedule III becomes actionable, not theoretical.

What the market will focus on next

• Operating cash flow trend

• EBITDA improvement

• Debt servicing ability post-280E relief

If last quarter showed:

• narrowing losses OR

• positive operating cash flow OR

• margin expansion

→ that gives credibility to future earnings re-rating, not just hype.

Why this changes risk

Without improved financials:

Schedule III = “hope trade”

With improving financials:

Schedule III = valuation reset candidate

That’s a big difference.

---

3 How this changes the price outlook

Let’s re-frame the earlier scenarios with this new info.

---

Updated Base Case (most likely now)

Short term (weeks):

• Volatile pullback continues

• 0.40–0.44 becomes defended

• RSI resets, volume fades

Medium term (1–3 months):

• Buyback absorbs dips

• Institutions start watching, not buying yet

• Price reclaims 0.50–0.55

Expected range:
0.42–0.60

This is constructive consolidation, not distribution.

---

Bullish Case (now more realistic)

If:

• Buyback is actually used, not just authorized

• Next earnings confirm trend improvement

• Sector sentiment stays constructive post-Schedule III

Then:

• 0.60 breaks and holds

• Retest of 0.70–0.72

• Possible extension toward 0.80+ over several quarters

This becomes a fundamental re-rating, not a momentum pop.

---

Bearish Case (now less likely, but still possible)

This happens only if:

• Buyback isn’t executed

• Next earnings disappoint

• Sector loses interest

Then:

• 0.40 breaks

• Drift toward 0.30–0.32

• Long base-building phase

But this scenario is weaker now than it was before your update.

---

4 Why today’s dump is actually less scary with this context

Without buyback + improving financials:

Today’s move = potential trend failure

With buyback + improving financials:

Today’s move = emotional washout + leverage reset

That’s often how sustainable uptrends begin.

---

5 What I would watch VERY closely (non-advice)

Bullish tells

• Repeated defense of 0.40–0.44

• Buyback disclosures in filings

• Volume declining on red days

• RSI stabilizing above 35–40

Bearish tells

• High volume breaks below 0.40

• No mention of buyback execution

• Weak next earnings despite Schedule III

---

Bottom line (plain English)

Schedule III gives the sector a reason to re-rate.
Improved financials give CXXI credibility.
A share buyback gives the stock a floor.

Short term = messy
Medium term = materially better than before

If you want, I can:

• Build a bull / base / bear price path chart

• Compare CXXI to peers without buybacks

• Translate next earnings into likely price reaction

Just say the word.

 

how does yesterdays Schedule 3 Exec. order help CXXI and what are timeline estimates?

 

Here’s a clear, practical breakdown of how yesterday’s Schedule III executive order helps CXXI (C21 Investments Inc.), what it means structurally, and reasonable timeline estimates based on how these reforms historically play out in cannabis markets.

---

What Schedule III Actually Does

Under the Controlled Substances Act:

• Schedule I: Cannabis was treated like heroin — no accepted medical use, high abuse potential.

• Schedule III: Cannabis is recognized as having medical use with less abuse potential than Schedule I/II drugs — similar to anabolic steroids or ketamine.

Key impacts of moving cannabis to Schedule III:
Federal agencies have clearer regulatory authority
Banks & financial institutions have reduced legal risk for cannabis clients
280E federal tax burden starts to meaningfully ease
Institutional investors have fewer legal hurdles
Insurance & payment processors become more accessible

This is a structural shift. It doesn’t legalize cannabis, but it massively reduces the legal risk premium.

---

How Schedule III Helps CXXI Specifically

1 Federal Tax Relief (280E)

Currently, cannabis companies cannot deduct typical business expenses due to 280E.
Under Schedule III:

• CXXI can deduct ordinary and necessary business expenses (rent, payroll, marketing)

• This improves net margins, cash flow, and operating profitability

This is the most important financial lever over the next 12–24 months.

---

2 Banking Access Improves

Banks have been reluctant to service cannabis companies due to federal risk.

With Schedule III:

• Banks are more comfortable offering accounts, lending, wire services

• Payment processors may expand support

• Cash handling risk drops

This lowers operational friction and strengthens balance sheets.

---

3 Institutional Participation

Institutional funds (pension, mutual funds, ETFs) are shocked by federal legality risk.

With Schedule III:

• Risk models improve

• Required compliance/legal buffers shrink

• Institutional allocation becomes more plausible over time

That can increase demand and uplift valuation multiples, but only after fundamentals validate profitability.

---

Typical Timeline Expectations

These aren’t exact, but reflect how markets tend to digest regulatory changes:

---

Immediate: 0–2 Weeks

Sell-the-news or knee-jerk volatility

• Traders sell news; price can dip even on good catalysts

• Liquidity and volume are low

• RSI oversold conditions common

This appears to be what you’re seeing on intraday charts.

---

Short Term: 1–3 Months

Market absorbs the implications
Analysts publish early takes
Some retail rediscovery rallies

During this stage, buybacks + improved financials help prevent decay and keep the down moves shallower.

---

Medium Term: 3–6 Months

The real fundamental benefits start kicking in:

• Companies begin recognizing tax benefits in earnings

• Financial models adjust net income expectations

• Banks experiment with services for compliant operators

At this point, improved quarterly results have real Fed-policy linkage, not just hope.

---

Long Term: 6–18+ Months

The structural impacts mature:

• Reliable banking relationships

• Deductible tax expense benefits

• Increasing institutional interest

• Sector re-rating

This is where your buyback + financial improvement tell a bigger story:
CXXI moves from speculation → valuation re-rating candidate.

---

How Stock Price Reacts Over These Phases

Here’s a realistic path, not a guarantee:

Phase	Price Behavior	Why
Immediate	Volatile / pullback	Buy-the-rumor, sell-the-news
Short Term	Range-trade / base	Digest implications
Medium Term	Gradual uptrend	Fundamentals start to catch up
Long Term	Re-rating & breakout	Tax benefit + banking access realized

---

What We Want to See Next

These are the true catalysts, not just headlines:

Better quarterly net margins (post-280E)
Positive operating cash flow
Buyback execution details (shrinking float)
Banking or lending partnership announcements
Institutional filings or ETF discussion

---

Wrap-Up: What This Means for CXXI

Short term:
Price may stay weak or chop — normal after news

Medium term:
Stabilization as fundamentals start to matter

Long term:
Stronger demand if earnings improve and tax benefits show up

Key drivers now:
Schedule III reduces federal risk
Buybacks support share price floor
Improving financials make the story real